Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02842736 · ClinicalTrials.gov registry record · NA
A CLinical Study to Evaluate the Safety And Effectiveness of the CeRene DevIce to Treat HeavY Menstrual Bleeding
A NA study, sponsored by Channel Medsystems.
- Completed
- Registry status
- NA
- Development phase
- 242
- Enrollment target
NCT02842736 is a NA study that has completed, run by Channel Medsystems. The registered enrollment target is 242 participants.
The verdict
NCT02842736, a NA study, has completed, sponsored by Channel Medsystems.
- COMPLETED
- Registry status
- NA
- Development phase
- 242 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate the safety and effectiveness of the Cerene Cryotherapy Device in reducing menstrual bleeding in women with heavy menstrual bleeding (menorrhagia) due to benign causes for whom child bearing is complete.
Interventions
- DEVICE Cerene(R) Cryotherapy Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 242 participants |
| Start Date | 2016-04 |
| Est. Completion | 2020-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02842736
The ClinicalTrials.gov registry entry for NCT02842736 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 242 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Channel Medsystems, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cerene(R) Cryotherapy Device is the first listed.
NCT02842736 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02842736 about?
NCT02842736 is a clinical study titled "A CLinical Study to Evaluate the Safety And Effectiveness of the CeRene DevIce to Treat HeavY Menstrual Bleeding". The purpose of the study is to evaluate the safety and effectiveness of the Cerene Cryotherapy Device in reducing menstrual bleeding in women with heavy menstrual bleeding (menorrhagia) due to benign causes for whom child bearing is complete.
What is the current status of trial NCT02842736?
This trial is currently completed. It is a NA study. The enrollment target is 242 participants. The study started on 2016-04. Estimated completion is 2020-05.
What interventions are being tested in trial NCT02842736?
The interventions under investigation include: Cerene(R) Cryotherapy Device (DEVICE).
Who is sponsoring clinical trial NCT02842736?
This trial is sponsored by Channel Medsystems, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.